Diajard-M 12.5mg/1000mg for Type 2 Diabetes
Pay in 3 Installments of
Rs.
101
JazzCash
easypaisa
NayaPay
Bank transfer
Cash on Delivery
Description
Diajard-M Tablets 12.5mg/1000mg – Dual Action Blood Sugar Control Therapy
Diajard-M Tablets 12.5mg/1000mg are a prescription oral antidiabetic medication used for the management of type 2 diabetes mellitus in adults. This combination therapy contains empagliflozin and metformin, working together to provide effective and sustained blood sugar control when lifestyle changes alone are not sufficient.
Empagliflozin lowers blood glucose by increasing its excretion through the kidneys, while metformin improves insulin sensitivity and reduces glucose production in the liver. This complementary action helps control both fasting and post-meal blood sugar levels without increasing the risk of excessive insulin release.
Diajard-M is particularly suitable for patients who require stronger glycemic control through combination therapy. When taken regularly alongside a balanced diet and physical activity, it supports long-term diabetes management and helps reduce the risk of diabetes-related complications.
This medication should be used strictly under medical supervision. Blood sugar monitoring is recommended to assess treatment effectiveness and adjust dosage if needed.
How to Order Diajard-M 12.5mg/1000mg at Derma.pk
At Derma.pk, we ensure the authenticity of Diajard-M Tablets 12.5mg/1000mg, verified by licensed pharmacists. Delivery is available across Pakistan. For prescriptions or inquiries, contact sales@derma.pk or WhatsApp +92-320-5999650.
Usage & Benefits
Dual action: empagliflozin removes glucose via kidneys while metformin reduces hepatic glucose production
Higher 1000mg metformin dose for stronger insulin-sensitising effect
Cardiovascular protection: empagliflozin reduces heart failure hospitalisation and supports kidney health
Low intrinsic hypoglycaemia risk — neither agent forces insulin release
Reduces pill burden by combining two essential diabetes drugs into one tablet
Well-established combination backed by extensive clinical evidence in type 2 diabetes
How To Use
Take one Diajard-M 12.5mg/1000mg tablet twice daily with meals to reduce metformin-related stomach upset. Swallow whole with water — do not crush or chew. Take with food to reduce stomach upset. Do not stop without consulting your doctor. Sick-day rule: temporarily stop during severe illness, dehydration, before contrast-dye imaging, or before surgery — consult your doctor immediately. Risk of euglycaemic diabetic ketoacidosis (DKA): seek emergency care if you experience persistent nausea, vomiting, abdominal pain, or unusual fatigue. May increase risk of genital yeast infections and urinary tract infections. May cause dizziness — sit or stand up slowly. Avoid heavy alcohol use. Have eGFR and vitamin B12 monitored periodically as directed by your doctor.
FAQs
Why does this combination use 1000mg metformin?
The higher 1000mg metformin strength is selected when patients need stronger insulin-sensitising and hepatic glucose-suppressing action alongside empagliflozin-based SGLT2 inhibition.
What are the sick-day rules for this tablet?
Temporarily stop Diajard-M during severe illness, vomiting, diarrhoea, dehydration, fasting, before contrast-dye imaging, or before surgery — both DKA and lactic acidosis risks increase with dehydration. Consult your doctor immediately.
What is lactic acidosis and how do I recognise it?
Lactic acidosis is a rare but serious side effect of metformin, more likely with dehydration, severe infection, alcohol misuse, or kidney impairment. Seek urgent care for unusual fatigue, muscle pain, breathlessness, or vomiting.
What DKA warning signs should I watch for?
Seek emergency care if you experience persistent nausea, vomiting, abdominal pain, or unusual fatigue — even if blood sugar appears normal. This is euglycaemic DKA, a known risk with SGLT2 inhibitors.
Is this combination safe with kidney disease?
Diajard-M 12.5/1000 is contraindicated below eGFR 45 mL/min. Your doctor will check kidney function before prescribing and monitor it regularly.
